Immunity, Inflammation and Disease is an open access peer-reviewed immunology journal publishing clinical and basic research in immunology and allied fields. Our journal is indexed in Medline and the Science Citation Index Expanded (part of Web of Science), among others. We welcome original work that reports well-conducted research with conclusions supported by data and will also accept articles containing negative or null results where appropriate and valid power calculations are included which demonstrate the negative result can be relied upon.

Journal Metrics

  • 4.4CiteScore
  • 2.7Journal Impact Factor
  • 30%Acceptance rate
  • 54 days Submission to first decision
view all metrics

As part of Wiley’s Forward Series, this journal offers a streamlined, faster publication experience with a strong emphasis on integrity. Authors receive practical support to maximize the reach and discoverability of their work.


Immunity, Inflammation and Disease is inviting applications for the role of Statistical Editor

We are excited to be seeking a Statistical Editor to build on the journal’s strong foundations and continue to develop Immunity, Inflammation and Disease as a core community resource. The deadline for applications is October 1st 2025. Please click here for further details about the role and how to apply.


Meet the Editor

Marc Veldhoen

Marc Veldhoen studied Medical Biology at Utrecht University, and then moved to National Institute for Medical Research (Mill Hill), UK. From 2010 to 2016 he was a group leader at the Babraham Institute in Cambridge, UK. He was awarded a prestigious ERC consolidator grant and was selected for the European Molecular Biology Organisation young investigator programme. In 2016 he moved to the Instituto de Medicina Moledular (iMM) in Lisbon, Portugal as the European Research Area chair. Where from 2018 he took up a position as professor of basic immunology at the Faculty of Medicine, University of Lisbon. His lab focus is T cell biology, with wide ranging interests from development and activation to differentiation, maintenance and metabolism. He made seminal contributions to CD4 T cell biology, such as the differentiation of Th17 and Th9 cells, and the role of the arylhydrocarbon receptor (AhR) in T cell biology. A large part of the lab is now dedicated to tissue resident T cells and the mechanisms that control their development, maintenance and activation. The clinical benefits are targeting the prevention of undesirable immune responses that may result in chronic infections, allergies and autoimmunity as well as strengthening our own immune responses against infection, such as using vaccination, as well as against tumours.

Articles

REVIEW ARTICLE
Open access

Molecular Mechanism of NLRP3 Inflammasome in Inflammatory Diseases and Tumors

  •  16 July 2025

Graphical Abstract

Molecular Mechanism of NLRP3 Inflammasome in Inflammatory Diseases and Tumors Issue 7, 2025

My review paper described the struction of NLRP3 inflammasomes and the actived mechanism of them. Then, sumerized the NLRP3 inflammasomes' function of inflammatory diseases and cancer.

ORIGINAL ARTICLE
Open access

Inflammatory Responses Potentiate GAS M Protein Induced Cardiac Damage in an Experimental Model of Rheumatic Heart Disease

  •  11 July 2025

Graphical Abstract

Inflammatory Responses Potentiate GAS M Protein Induced Cardiac Damage in an Experimental Model of Rheumatic Heart Disease Issue 7, 2025

Group A streptococcal M protein elicit antibody and T-cell responses that cross react with cardiac and connective tissue proteins in the Rat Autoimmune Valvulitis (RAV) model of rheumatic heart disease. Bordetella pertussis Toxin induce a robust Th1 response that potentiates the autoimmune process in the RAV model A robust Th1/Th17 response was found to be a major driver of cardiac pathology in the RAV model

ISSUE INFORMATION
Open access

Issue Information

  •  8 July 2025
More articles

The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.

Open access

Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease

  •  59-73
  •  17 December 2020

Graphical Abstract

Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease Issue 1, 2021

Obesity plays a vital role in the development of associated nonalcoholic fatty liver disease by affecting several inflammatory reactions via adipose tissue, vascular, intestinal, skeletal muscle, and brain, this process is associated with adipose tissue inflammation, inflammatory factors in the blood, intestinal inflammation, skeletal muscle inflammation, and brain tissue inflammation.

Open access

Relationship between oral and gut microbiota in elderly people

  •  229-236
  •  15 July 2019

Graphical Abstract

Relationship between oral and gut microbiota in elderly people Issue 3, 2019

Recent studies have shown that oral bacteria might induce systemic inflammation through alteration of gut microbiota. We investigated the relationship between oral and gut microbiota and evaluated the transition of oral bacteria to the gastrointestinal tract. Unweighted UniFrac distance revealed that the elderly group had a higher similarity between fecal and subgingival plaque microbiota than the adult group. Moreover, a significantly higher prevalence of some bacterial taxa found in oral samples was observed in the feces of the elderly group than of the adult group. Our results suggest that the prevalence of oral bacterial transition to gut is higher in the elderly than in adults; thus, we expect that in the elderly, oral health care will affect gut microbiota composition and consequently promote human health.

Open access

Improved B cell development in humanized NOD-scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3

  •  427-440
  •  28 August 2016

Graphical Abstract

Improved B cell development in humanized NOD-scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3 Issue 4, 2016

In this study, we have used the NSG-SCF/GM-CSF/IL3 (NSG-SGM3) strain of mice engrafted with human fetal thymus, liver, and HSC (BLT) to establish a novel humanized mouse model with enhanced human B cell development and function. A higher proportion of human B cells developing in NSG-SGM3 BLT mice had a mature/naive phenotype with a corresponding decrease in immature/transitional human B cells as compared to NSG BLT mice. Dengue virus infection of NSG-SGM3 BLT mice generated higher levels of antigen-specific IgM and IgG, a result not observed in NSG BLT mice.

Open access

Does COVID‐19 contribute to development of neurological disease?

  •  48-58
  •  17 December 2020

Graphical Abstract

Does COVID-19 contribute to development of neurological disease? Issue 1, 2021

This review correlates present clinical manifestations of coronavirus disease 2019 patients with possible neurological consequences. Recent studies suggest that activated glial cells contribute to neuroinflammation and the devastating effects of severe acute respiratory syndrome coronavirus 2 infection on the central nervous system.

More articles

Latest news

Recent issues